Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting.

Yawn BP, et al. Int J Chron Obstruct Pulmon Dis. 2012;7:495-502.

Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians.

Yawn BP, Thomashow B. Int J Gen Med. 2011;4:665-676.

Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.

Puhan MA, et al. Cochrane Database Syst Rev. 2016;12:CD005305.

An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.

Spruit MA, et al. Am J Respir Crit Care Med. 2013;188(8):e13-e64.

Reducing chronic obstructive pulmonary disease hospital readmissions. An official American Thoracic Society workshop report.

Press VG, et al. Ann Am Thorac Soc. 2019;16(2):161-170.

Triple versus dual inhaler therapy in moderate‐to‐severe COPD: a systematic review and meta‐analysis of randomized controlled trials.

Zayed Y, et al. Clin Respir J. 2019;13(7):413-428.

Once-daily single-inhaler triple versus dual therapy in patients with COPD.

Lipson DA, et al. N Engl J Med. 2018; 378(18):1671-1680.

Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicenter, phase 3 randomized controlled trial.

Ferguson GT, et al. Lancet Respir Med. 2018; 6(10):747-758.

Patient Advocacy Organizations and Resources

American Lung Association

The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy, and research.

COPD Foundation

The COPD Foundation’s mission is to prevent and cure COPD and to improve the lives of all people affected by COPD.

Global Initiative for Chronic Obstructive Lung Disease (GOLD)

GOLD partners with health care professionals and public health officials to raise awareness of COPD and to improve prevention and treatment of this lung disease for patients around the world.

National Jewish Health

National Jewish Health integrates the latest scientific discoveries with coordinated care for lung, heart, and immune diseases. Their Patient Education Program provides many free educational opportunities and support groups to assist patients and caregivers with managing illnesses and chronic conditions, such as COPD.